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derived from a dataset of 50 subjects of whom 10 had the 
disease in question. Further guidelines for the evaluation of 
decision rules are provided in reference 7. 
Rules for interpreting diagnostic literature are given in 
Table V. 1" 15 It is useful to remember that the following 
principles apply to all medical literature: (i) is the study valid?; 
(ii) what are the results and their level of precision?; (iii) can I 
apply these results in my practice? 
Diagnostic research is still in its infancy and the clinician can 
look forward to better ways of overcoming uncertainty 
regarding ruling disease in or out. However, it is imperative 
that the clinician understands and applies the principles related 
to diagnostic research and reasoning in order to ensure optimal 
patient management. 
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PREVALENCE OF PRE-CANCEROUS 
LESIONS AND CERVICAL CANCER 
IN SOUTH AFRICA - A 
MULTICENTRE STUDY 
S Fonn, B Bloch, M Mabina, S Carpenter, H Cronje, C Maise, 
M Bennun, G du Toit, E de Jonge, I Manana, G Lindeque 
Objectives. To describe the age-specific prevalence rates of 
cancer of the cervix in South African women presenting for 
screening. 
Design. A multicentre prevalence survey in 10 geographically 
defined areas following a common core protocol. Services 
were located in existing service sites, witl:l the exception of 
KwaZulu-Natal which used a mobile service. Women aged 20 
years and above were eligible for inclusion. 
Outcome measures. Age-specific cervical cytologically 
diagnosed abnormality rates according to the Bethesda 
classification. 
Results. During the study 20 603 women participated. Eighty 
per cent of the sample had never had a Pap smear before and 
just over 91 % .had not had a Pap smear in the last 5 years. In 
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this study population 468 women screened (2.42%) were 
found to have low-grade squamous intra-epithelial lesions 
(LSIL) and the average age of these women was 33.1 years; 
366 (1.8%) had high-grade SIL (HSIL) and these women were 
statistically significantly older at 37.97 years of age; and 92 
women (0.47%) were found to have cytologically diagnosed 
invasive cancer. These women were significantly older, with 
an average age of 51.3 years. A clear relationship was found 
between age and LSIL, with younger women having a high 
rate of LSIL which decreases with increasing age. A similar 
but inverse relationship between age and invasive cancer is 
described, with the rate being low in young women and 
increasing with increasing age. A clear relationship between 
HSIL and age is not described in these data. The adequacy 
rate (satisfactory and satisfactory but limited) of the slides 
was 95%, and just under 92% of the study sample received 
their results. Not all women were appropriately referred and 
it was not possible to assess if women referred for treatment 
received it. 
Conclusions. These data indicate that cancer of the cervix is a 
common disease and that, similar to other countries, it is a 
disease of older women. These data give some positive 
indicators for future screening - older women will present 
for screening and the majority of women received their 
results. However, improvements in health system functioning 
are needed. A uniform national cytology reporting system is 
required as well as clear guidelines for providers on what 
action to take based on cytology reports. Linkage between the 
site of screening and treatment centre is inadequate and 
requires urgent attention in order to decrease cervical cancer 
mortality. 
S Afr Med J 2002; 92: 148-156. 
Cervical cancer is the most common cancer in South African 
women' and is one of the few cancers, perhaps the only one, 
where screening can identify pre-cancerous lesions, and where 
an association between screening and mortality decline has 
been demonstrated."' Mortality from cervical cancer has been 
decreasing in developed countries and this decrease has been 
faster and more sustained in countries with organised national 
screening programmes.'·' The call for a rational national 
screening programme for cervical cancer in South Africa has 
been made for at least the past 30 years.6 While the cost 
effectiveness of cervical cancer screening has been 
demonstrated7•8 there has nonetheless been debate about 
whether South African health care services are sufficiently 
developed to be able to sustain cervical cancer screening.'·12 
Cervical cancer is a disease of older women.13•14 South African 
Cancer Registry data indicate that in the age category 20 - 24 
years approximately half a million women would have to be 
screened to find 1 case of cervical cancer, whereas in the age 
category 35 - 40 years, 4 000 women would have to be screened 
in order to identify 1 case of cervical cancer.1 It is evident that 
the cost effectiveness of screening and the resource allocation 
and time that women would have to invest in order to impact 
on cervical cancer mortality are very significantly influenced by 
the age group screened. World Health Organisation (WHO) 
guidelines advise commencing screening approximately 'one to 
two years before the incidence of invasive disease reaches 
appreciable levels'.15 The South African Department of Health, 
using best available data and taking into account resource 
constraints, has therefore approved a national screening policy 
to screen all women in South Africa over the age of 30 years." 
Cancer registry data reflect histologically diagnosed cancer 
reported to the registry and in the 1993 - 1995 report doubts 
about cervical cancer incidence, which may be inappropriately 
low, are raised. 17 There has been concern among clinicians that 
cervical cancer occurs in younger women in South Africa; 
however, this has not been documented and may possibly 
reflect the profound impression that a young woman with 
cancer makes on a clinician. There are data to suggest that in 
HIV-positive women the disease may progress faster. However, 
it should be noted that while HIV-positive women with 
invasive disease appear to be about 10 years younger on 
average than HIV-negative women, their average age is 
nonetheless over 40 years" which is still 10 years older than the 
age at which the current policy proposes to begin screening. 
In order to address the age-specific rates of cervical cancer a 
multicentre study was undertaken to determine the prevalence 
of cervical abnormalities, focusing on unscreened South 
African women aged 20 years and above. 
The primary objective of the study was to determine the age-
specific prevalence of cytological abnormalities in a population 
of South African women. In addition study data on the number 
of patients who received their results and whether appropriate 
action was taken provide some indication of the capacity of the 
health service to implement cervical screening services. 
METHODS 
Women 20 years and older, preferably those who had never 
had a Pap smear, but also those who had not had a Pap smear 
within the last 5 years, were eligible for inclusion. Pregnant 
women were not excluded. From least-likely estimates of 
cervical cancer prevalence 1 000 women per 5-year age 
nr."I category were required, starting at 20 - 24 years and extending ll,liM 
to age 60 and above. In order to gain such a sample in a 
reasonable time period and to include women from all over 
South Africa, a multicentre population-based prevalence 
survey was undertaken. Following a common protocol each 
participating obstetrics and gynaecology department at six 
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universities chose a site, either because of a previous· 
relationship with the area or because it was an under-served 
area. Each area was geographically circumscribed and within 
that geographical area women in the target population were 
informed, using various methods ranging from home visits to 
educational campaigns, about the study and encouraged to 
attend for a Pap smear. In order to simulate a screening 
programme maximally, existing services and service 
infrastructure were used. In some areas services were 
integrated into existing health care services provided by 
existing staff. Where this was not possible appropriately 
trained staff were specifically employed to take the Pap smears. 
In either circumstance women who were recruited attended 
existing health care facilities and for further care the usual 
referral mechanisms were used. Care of individuals with 
abnormalities was the responsibility of the principal researcher 
at each of the study sites. The exception to this method was in 
KwaZulu-Natal where a remote under-served rural area was 
chosen. A mobile clinic staffed by a gynaecologist travelled to 
the area to perform Pap smears and provide follow-up services 
as well as transporting women who required tertiary care. 
At least one study site in each province was established and 
while these sites were not representative of the entire province, 
the study as a whole collected data from highly urbanised 
areas with formal housing, township and squatter areas, and 
peri-urban and rural areas. Thus the range of living 
circumstances in South Africa was represented in the total 
study sample. Each site used a standard data collection form. 
Pap smears were processed by the laboratory servicing the 
study area and a pre-agreed standardised interpretation .and 
reporting system was used. Data were forwarded to a central 
data manager, coded, entered onto a mainframe computer and 
analysed using the Statistical Analysis System (SAS) package. 
Statistical consultancy was provided by the Department of 
Statistics and Actuarial Science at the University of the 
Witwatersrand and analysis was done by the Data 
Management and Statistical Analysis (DMSA) unit at the same 
university. Ethical approval for the study was obtained from 
the relevant university by each principal researcher and all 
participants completed a uniform written consent form. 
ANALYSIS 
The descriptive data for the total study population and site-
specific data are presented. Site-specific data are presented to 
describe the range of conditions and services across South 
lmiJ Africa. Site-specific health system performance within each site 
is also presented for the same reason. In relation to cervical 
cancer prevalence the reliability of the results are determined 
by the sample size and only the pooled data provide sufficient 
numbers within each age category. Thus prevalence data for 
the entire study sample are presented. It should be noted that 
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in North West there were two study sites and in the descriptive 
data these two sites are presented separately as North West 
and Hammanskraq.l. In other analysis they have been 
combined as North West. 
When comparing rates between sites and in developing the 
projections for South Africa, age was standardised to the South 
African population. Province-specific projections of cervical 
abnormality have been created by applying the pooled rates to 
the province-specific ages. 
In analysing the age trend normal and low-grade squamous 
intra-epithelial lesions (LSIL) were combined into one category 
and high-grade intra-epithelial lesions (HSIL) and invasive 
disease formed the other two categories. The reason for this 
was, as data indicate, that the majority of LSIL revert to 
normal," while women with HSIL and invasive disease should 
be referred for immediate investigation and appropriate 
treatment. Women with LSIL should be followed up to assess 
their cervical health status. 
Analysis investigating the correlation between descriptive 
variables and the outcome (cervical health) first focused on 
bivariate analysis. In these analyses cervical health was initially 
defined into the three categories described above: normal 
(combining normal and LSIL), HSIL, and invasive squamous 
carcinoma; and also into two categories: normal (combining 
normal and LSIL), and abnormal (combining HSIL and 
invasive disease). The trends obtained were similar using either 
categorisation and therefore for simplicity the rates using the 
two categories were employed to build a logistical regression 
model. All the variables thus found were included in a 
stepwise analysis which progressively excluded variables that 
were not statistically significant. 
RESULTS 
Descriptive characteristics 
During the study period 20 603 individuals had Pap smears; of 
this number 326 were exduded because they were not in the 
study age range or age data were missing. For 591 women no 
laboratory data were received. because the data forms, 
cytological slides or laboratory reports were either lost or not 
returned in time to comply with the study cut-off date. These 
individuals were nonetheless included in the overall numbers 
of the study as they had presented for a Pap smear. The 
individual sites contributed different numbers of individuals to 
the study (Fig. 1) and differed in their age structure, with 
KwaZulu-Natal and Northern Province comprising older study 
samples and North West and Mpumalanga comprising the 
youngest study samples. Sites also differed in predictable 
ways, for example electricity and water in the home were more 
common in urban compared with rural sites. Besides the 
KwaZulu-Natal site, which had a lower average level of 
education (Std 2), the average highest educational level was 
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Fig. 1.. Percentage contribution of each site to the study population. 
similar across the sites (Std 5 - 6). While pregnant women were 
not excluded from the study, only 5.8% of the total study 
population were pregnant. This ranged from less than 1 % to 
7% between the sites; excluding the Western Cape where 19.6% 
of the sample were pregnant (data not presented). The sites 
also differed in terms of the percentage of women using 
contraception. Contraception use was higher in the sites with a 
younger average age and lower in the sites with an older 
average age. On average in this study population women had 
2.9 children and the age of first intercourse was similar across 
the sites. The descriptive characteristics of the study population 
are presented in Table I. 
Further descriptive data more specific to cervical health are 
presented in Table II. The proportion of women who reported 
never having had a Pap smear previously ranged from 29.5% 
in the Western Cape to 97.1 % in North West. For the total 
Table I. Descriptive characteristics of the population 
population, 80% reported never having had a Pap smear 
previously and 92.l % of the total population reported not 
having had a Pap smear in the past 5 years. 
Overall, 70.5% of the total population attended the health 
service specifically for a Pap smear, mostly in response to 
information from clinic staff or because of the advertising 
initiated as part of the research project (Table III). Almost half 
the study population (49.8%) reported having a vaginal 
discharge; this ranged from 38.8% in Northern Province to 
99.2% in North West. On examination 37.5% of the women 
were described by the Pap smear takers as having a discharge 
(ranging from 17.3% in the Northern Cape to 94% in North 
West). It should be noted that in the North West site specially 
trained lay women did the interviews and took the Pap smears. 
The source of information regarding the availability of 
screening was similar for all sites, predominantly clinic staff 
(47.5%) or adverts specifically about the study on the mass 
media (42.1 %) (Table III). The major reason for coming for a 
Pap smear (again similar across all sites) was to ensure good 
health and exclude cancer (Table IV). 
The smear was reported as satisfactory or unsatisfactory for 
interpretation by each of the participating laboratories. Initially 
a set of standard slides were circulated in an attempt to 
develop uniformity in reporting. Laboratories used the 
Bethesda classification, therefore slides were classified as 
satisfactory, satisfactory for evaluation but limited (either by 
Eastern Western Northern Northern Mpuma- Free North KwaZulu· Hammans-
Variable* Total Cape Cape Cape Province langa Gauteng State West Natal kraal 
Age (yrs) 37.7 38.90 36.46 36.92 39.62 34.80 35.9 37.07 34.19 43.07 33.63 
(20 - 95) (20 - 95) (20 - 80) (20 - 80) (20 - 89) (20 - 68) (20- 80) (20 - 82) (20- 88) (20 - 90) (20 - 73) 
11.77 12.24 9.2 11.09 11.91 10.38 10.75 9.94 10.04 14.97 10.93 
Gravidity 3.5 3.17 2.96 3.16 3.90 3.03 2.73 3.37 3.34 4.5 2.97 
(0 -15) (0 -15) (0 - 14) (0 -15) (0 - 15) (0 - 12) (0 - 13) (0-15) (0 - 15) (0- 15) (0-12) 
2.45 2.28 1.92 2.28 2.5 2.4 '2.3 2.33 2.20 2.98 1.96 
Parity 2.9 2.64 2.63 2.62 3.40 2.53 2.35 2.68 2.73 3.2 2.46 
(2-12) (0 - 10) (0 -12) (0 -12) (0-12) (0 - 11) (0 -10) (0 -12) (0 -12) (0-11) (0 -12) 
2.03 1.85 1.88 1.9 2.23 1.94 1.9 2.33 1.8 2.2 1.96 
Age of 17.8 17.90 18.10 18.40 18.07 17.49 17.42 17.55 17.54 17.7 16.73 
coitarche (yrs) (7 - 32) (9-32) (11- 32) (9 - 31) (7 - 32) (11 - 28) (10- 26) (11 - 30) (10- 29) (10 - 30) (11 - 28) 
2.52 2.7 2.9 2.7 2.5 2.3 2.3 2.43 2.04 2.5 2.14 
Using 45 45 48.6 55.8 35 53 45.3 41.2 63.5 22.9 49.7 
contraception(%) 
Electricity 58.5 64 94 88.9 50.7 75.8 91.5 73.8 18.6 23.6 96.7 
at home(%) 
Running 47.7 88 82.5 86.4 36.7 61.2 92.1 67.9 9.6 8.4 9.3 
water in the house(%) 
Highest educatio- Std5 Std 6 Std5 Std5 Std 6 Std6 Std6 Std5 Std5 Std2 Std6 
nal level achieved 4.05 3.7 2.9 3.67 4.4 2.3 3.4 3.3 4.1 4.1 3.8 
(mean, SD) 
*Mean (range) SD, unless otherwise specified. 
-------------------------- -- -- --
ml 
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Table II. Cervical screening characteristics of the study population* 
Eastern Western Northern Northern Mpuma- Free North KwaZulu- Hammans-
Total Care Cape Cape Province langa Gauteng State West Natal kraal 
Never had a 80.6 67.7 29.4 50.8 91.7 82.6 86.6 84.5 97.1 95.3 93.4 
Pap smear 
before(%) 
No Pap smear in 92.1 83.9 97.9 71.5 94.4 93.0 94.1 89.7 98.9 98.7 97.1 
the last 5 years(%) 
Came to 70.5 46.5 70.2 87.2 58.3 41.6 87.1 75.5 75.5 95.9 60.7 
service for a 
Pap smear 
specifically ( % ) 
Report having 49.8 58.3 41.9 44.9 38.8 53.2 52 73.9 99.2 94.1 50.9 
a discharge(%) 
Cervix 98.7 99.5 99.4 96.4 98.2 97.2 97.9 99.8 97.1 95.3 93.4 
visualised(%) 
Discharge/ 37.5 46.5 92.7 17.3 47.5 63.4 66 39.1 94 70.1 81 
blood present(%) 
* Data missing for 1 082 people. 
tNot specific to the cervical smear result and often reflected a clinical condition such as a discharge. 
Table lll. Sources of information about screening availability* 
Source N % 
Clinic sister 9 435 47.5 
Advert, campaign, radio 
From a friend/neighbour 
Knew anyway 
Other 











To confirm health/ exclude cancer 16593 86.4 
Had current gynaecological problem 1722 9 
Part of routine antenatal service 340 1.8 
Previous gynaecological problem 260 1.4 
Never had one before 159 0.8 
Hoped to get pregnant 64 0.3 
Sexual dysfunction 55 0.3 
Other 2 
• Data missing for 1 082 people. 
blood, discharge or inadequate cellular component) or 
unsatisfactory for evaluation where no diagnosis could be 
made. Some laboratories noted slides as being unsatisfactory 
but the cytologist nonetheless gave a definitive report and 
therefore could in fact read the slide. In this study such slides 
have been reported as satisfactory for evaluation but limited. 
The overall data on slide satisfactory rates and the site-specific 
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data are reported in Table V. Overall the satisfactory rate was 
high at 80.6% and 95% of smears were reported on (reflecting 
both the satisfactory and satisfactory but limited categories). 
Only 1.6% of slides were unreadable and had to be repeated. 
In this study population 468 women screened (2.42%) were 
found to have LSIL and the average age of these women was 
33.1 years (range 20 - 84 years); 366 women (1.9%) had HSIL 
and these women were statistically significantly older at 37.97 
years of age (range 20 - 84 years); and 92 women (0.47%) were 
found to have cytologically diagnosed invasive cancer. The 
average age of women with invasive disease was 51.3 years 
(range 27 - 82 years), statistically significantly older than the 
rest of the sample. Stat.istical significance was determined using 
analysis of variance and multiple comparison t-tests, and a 
P-value of 0.0000 was used for all comparisons quoted. 
Distribution of cervical abnormality (number and 
percentage) by age category is presented in Table VI. There is a 
clear relationship between age and LSIL, with younger women 
having a high rate of LSIL which decreases with increasing age 
(P-value from chi-square< 0.001). A similar but inverse 
relationship between age and invasive cancer is described with 
the rate being low in young women and increasing with 
increasing age (P-value from chi-square< 0.001). A clear 
relationship between HSIL and age is not described in these 
data. 
A similar pattern of higher rates of invasive disease with 
increasing parity was also demonstrated (data not shown). 
However, age and parity are significantly correlated (Pearson's 
correlation coefficient= 0.51769, P < 0.0001) and it is not 
possible to separate out these effects. 
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Table V. Smear satisfaction rates by site and overall 
Satisfactory 
Satisfactory but limited Unsatisfactory 
Regi_o_n~~~~~~~~~N~~~~o/t_o~~~~~N~~~~o/t_o~~~~-N~~~~o/t_o~~~-M_i_ss_i_ng"'-(N)~~~-1_o_ta_l_(_N)~~ 
Eastern Cape 1 590 77.9 408 20.0 25 1.2 17 2 040 
Western Cape 1 221 82.8 182 12.3 64 4.3 7 2 040 
Northern Cape 1 589 76.2 189 9.1 19 0.9 289 2 086 
Northern Province 4 548 89.8 408 8.1 21 0.4 90 5 067 
Mpumalanga 356 82.8 60 14.0 9 2.1 5 430 
Gauteng 867 91.1 52 5.5 0.1 32 952 
Free State 1 586 86.6 186 10.2 42 2.3 17 1 831 
North West 2 860 90.3 127 4.0 38 1.2 142 3 167 
KwaZulu-Natal 732 34.9 1 175 56.0 107 5.1 84 2 098 
Hammanskraal 987 87.2 130 11.5 6 0.5 9 1 132 
Total 16 336 80.6 2 917 14.4 332 1.6 692 20 277 
Table VI. Distribution of cervical abnormality (number and%) by age category* 
Squamous Columnar 
Total for study and 
proportional age 
distribution for 
study and South invasive invasive 
Normal 
(37.7 (12.2))' 
ASCUS AGUS LSIL HSIL carcinoma carcinoma African population 














4 366 91.28 
3 455 92.16 
2 944 90.92 




1 130 91.20 
17 737 91.56 
• Data missing for 906 people. 












N % N % N % N % N 
1 0.12 52 6.39 14 1.72 0 0 0 
6 0.13 156 3.26 70 1.46 2 0.04 
5 0.13 86 2.29 72 1.92 8 0.21 
7 0.22 81 2.50 82 2.53 8 0.25 
8 0.37 41 1.88 55 2.52 15 0.69 
5 0.32 24 
5 0.50 11 
1 0.12 10 
6 0.48 7 
44 0.23 468 
1.56 23 1.49 
1.09 13 1.29 
1.23 17 2.08 
0.56 20 1.61 


























N % populationt) 
814 4.2 (17.5) 
4 783 24.7 (15.2) 
3 749 19.4 (13.7) 
3 238 16.7 (11.6) 
2 185 11.3 (9.4) 
1 540 8.0 (7.3) 
1 007 5.2 (5.7) 
816 4.20 (5.0) 
1 239 6.4 (14.6) 
19 371 
tProportion of women in South Africa 20 years and older in each age group in the general population using 1996 census data (note denominator = all women 
20 years and older). 
ASCUS = atypical squamous cells of undetermined significance; AGUS = atypical glandular cells of undetermined significance; LSIL = low-grade squamous 
intra-epithelial lesions; HSIL = high-grade squamous intra-epithelial lesions. 
Source: http://www.statssa.gov.za/census96/H1ML/CIB/Population/218.htm. 
Table VII presents the results from the logistical regression 
model. The first column indicates the variables which were 
found to be significant from the stepwise procedure in 
predicting the presence of an abnormal outcome (HSIL and 
cytologically diagnosed carcinoma) versus a normal outcome 
(normal and LSIL). Table VII shows that for every increase of 1 
year in age the risk of contracting carcinoma increases 1.013 
times (P = 0.0090), and similarly for each additional birth the 
risk of contracting carcinoma increases 1.076 times (P = 0.0085). 
The odds of having carcinoma are 1.309 times higher for those 
with clinically noticeable cervical discharge or blood present 
Table VII. Summary of logistic regression model 
Parameter 






Cervical discharge or 
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(P = 0.0150) than for those without. The corresponding odds 
are 0.557 for those whose cervix appears to be macroscopically 
normal on clinical examination (P = 0.0001), that is they ar~ less 
likely to have an abnormal outcome. 
In order to assess patient follow-up two sets of data were 
recorded. Firstly, data were recorded on the percentage of 
participants who received their results. These data are 
presented by site and overall in Table VIII. For the entire study 
population 92.9% of participants got their results, ranging from 
99.5% in Northern Province to 51 % in Hammanskraal. The 
method of communicating the result was similar in all sites and 
the composite data are presented in Table IX. Aimost all the 
results were communicated to patients on their return visits. 












*Data missing for 1 249 indMdu<!ls. 
Table IX. Method of communicating results* 
Face to face 
Home visit 
Letter I message sent 
Did not come back 
Telephone 
Combination of above 


























Appropriate recognition of patients requiring follow-up was 
determined by assessing if patients requiring a repeat Pap 
smear were recognised and asked to come back. Overall 2 094 
patients (11.81 %) were noted to require a repeat Pap smear. 
One thousand one hundred and seventy-nine women with 
normal results (7%) were incorrectly noted to require a repeat 
Pap smear; 520 women (82.3%) and 30 women (58.8%) with 
atypical,squamous,cells of undetermined significance (ASCUS) 
and atypical glandular cells ofundetermined significance 
(AGUS) respectively were (correctly) noted to require a repeat 
Pap smear as well as 306 women with LSIL (74.6%). Forty-
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seven women (14.9%) with HSIL, 11 women (13.4%) with 
squamous invasive disease and 1 woman (10%) with columnar 
invasive disease were (incorrectly) identified as requiring a 
repeat Pap smear. 
Overall the trend was to repeat Pap smears for people with 
ASCUS, AGUS and LSIL. However, a small proportion, but a 
high number, of women with normal results were noted to 
require a repeat Pap smear. In addition, women who had HSIL 
and invasive disease should have been referred for definitive 
treatment and not for repeat cytological examination. 
Of the 423 individuals who were diagnosed as having either 
HSIL or invasive disease and for whom there were follow-up 
data recorded, 393 (92.9%) were noted as requiring referral for 
definitive treatment. 
DISCUSSION 
This study draws its sample from a range of geographical sites 
and the differences between the study sites represent the 
diversity of conditions and services in South Africa. The age 
distribution of the sample, with the exception of the 20 - 24-
year age groups and the over-60 age groups which are 
proportionally underrepresented in this sample, reflects the age 
structure of the South African population as indicated in Table 
VI. This study represents the largest community-based sample 
of cervical abnormality in South Africa. Both the large age-
specific sample size and the similarity of the proportional 
representation of the age structure of the population allow for a 
degree of confidence in extrapolating these data to the overall 
South African female population. 
These data indicate that 1.88% of the study population have 
HSIL, with an average age of just below 38 years, and therefore 
support the current South African cervical screening policy 
which is to screen women 30 years and older. These data also 
support the existing epidemiological data, "Yhich have 
established that cervical cancer is a common disease. It is clear 
from this study that there is a definite age relationship between 
LSIL and invasive disease, the former beh1g common in 
younger women and decreasing with age, probably owing to 
regression to normal without any intervention/' and the latter 
increasing with increasing age. The absence of a clear 
relationship between age and HSIL may be because this entity 
is a combination of cervical intraepithelial neoplasia (CIN) II 
and CIN III where CIN II decreases with increasing age and 
CIN III increases with increasing age and when combined the 
more uniform presentation of HSIL across all age groups is 
described as found in this study population. 
Providing a screening service 
The study population, while differing between sites, 
nonetheless represents a cross-section of the population likely 
to present for cervical screening services at public sector 
primary health care (PHC) clinics in South Africa. With 
relatively limited expenditure on advertising the service, 70% 
of women attended services specifically for a Pap smear. In 
KwaZulu-Natal and Northern Province in particular this 
included a significant number of older women. This indicates 
that there is receptiveness to, and a felt need for, cervical cancer 
screening among older women. Furthermore, in spite of 
problems in delivering services it was possible for the service 
to take, process and report on Pap smears. In some areas, in 
particular Northern Province, this worked well. With the 
exception of the Hammanskraal site, over 90% of patients 
returned for their results. This is another positive indicator for 
the potential of a national screening programme. Most women 
received their results in face-to-face consultations, which is 
hardly surprising given the weakness of existing infrastructure 
(post and telephone). This also reflects that the women made 
the effort to return despite the added burden this places on 
them. While face-to-face consultation for communicating 
results increases the workload of PHC staff, it is also an 
opportunity for health promotion with regard to women who 
are well, and in cases where an abnormality was noted it is an 
opportunity to motivate women to go for treatment and to set 
up appointments. So long as the communication infrastructure 
remains weak the need for face-to-face consultation will 
remain. To ensure that this is possible and that patients can 
return with relative ease it is essential that the decentralisation 
of screening services be maximised. It is also essential that a 
known and reliable result turnaround time be established so 
that women can be asked to return appropriately and that, 
when they do, their results will be available. 
A major weakness both of this study and of the organisation 
of health services is the difficulty in determining whether 
patients with abnormalities requiring treatment do return and 
receive appropriate treatment. Methods to link patient data 
between PHC and referral sites do not exist. This aspect of 
PHC services, namely communication between referring and 
referral centres, needs to be strengthened to ensure continuity 
of care for patients, to provide feedback and motivation to staff 
and to provide data from which to assess if interventions are 
having the desired impact. 
Appropriate follow-up 
Although it is possible that the data forms were incorrectly 
completed it appears that guidelines for patient management 
and follow-up are not clearly defined. While it is justifiable to 
recall women requiring a repeat smear because of an 
unsatisfactory initial slide, the recall of women with normal 
results places an unnecessary burden on the health service. 
Failure to identify women requiring repeat smears and 
inappropriate repeating of Pap smears in cases requiring 
definitive treatment represent lost opportunities for preventing 
disease and possibly even death. In providing screening 
services patients are promised positive health benefits, so it is 
essential that appropriate action be taken and it is unethical for 
the wrong decision to be made.20 Thus in instituting a screening 
programme clear guidelines must be developed and service 
providers and communities need to be made aware of these to 
ensure that responsibility for appropriate action is taken. 
Variation in laboratory standards, particularly with regard to 
the uniform application of the Bethesda system, needs to be 
investigated. In this study slides were reported as being 
unsatisfactory but were in fact read, and.are therefore likely to 
fit into the 'satisfactory but limited' category. The implication 
of this is that should results be called unsatisfactory the patient 
is advised to have a repeat Pap smear. In one study site this 
occurred in 50% of the sample. Clearly guidelines on taking 
Pap smears and uniformity in the interpretation of the 
Bethesda system are required. The cost to the health service 
and to the patient of unnecessary repeat smears is significant. 
A system that is uniform and where quality control systems are 
in place is essential for a national programme. 
The logistical regression analysis, while of interest, shou.ld 
not be over-interpreted as a prevalence survey is not the most 
appropriate design to investigate causal relationships. This is 
more so in cancer research where the outcome of interest is 
relatively rare. Nonetheless these data are consistent with other 
data where cervical cancer is related to age and parity.'·5•15•19 The 
finding that the clinical condition of the cervix is related to the 
finding of cytological abnormality (HSIL and cytologically 
diagnosed squamous carcinoma) is not surprising, but in this 
design it is hard to interpret as which condition precedes the 
other cannot be determined. 
It should be noted that the rate of cervical abnormality 
differed between sites and when site was included in the 
regression model cervical abnormality was found to be 
associated with some of the sites. Possibly age differences 
between the sites can explain this; however, age-standardised 
prevalence still indicated differences between sites. The finding 
of no explanation of the different rates between the sites can be 
understood in numerous ways. Firstly, the age-specific 
numbers within each site are small, and care should be taken 
not to over-interpret these differences when such small 
numbers are studied. The descriptive data collected as part of 
this survey do not explain the differences. The differences may 
be a selection bias. It is possible that the location of services, 
e.g. in a gynaecology clinic, as was the case in the Northern 
Cape study compared with PHC services in most of the other 
studies, may explain the variation. However, no specific 
conclusions can be drawn from these data. 
CONCLUSIONS 
Overall this study described the prevalence of pre-cancerous 
cervical lesions and cytologically diagnosed cervical cancer in 
BI'I 
~ ORIGINAL ARTICLES 
South Africa. It is the first large multicentre study of its kind in 
the country. The following conclusion can be drawn from these 
data: (i) cervical cancer is a common disease and the rate of 
serious cytological abnormality increases with age; (ii) despite 
the limited investment in system functioning that is essential to 
start a programme, it was possible to take smears and report 
the results to patients; (iii) these data support the current policy 
to screen older women; (iv) health systems research should be 
instituted to establish the requirements for a sustainable high-
quality screening programme in South Africa; (v) patients will 
attend for services and follow-up; (vi) methods to link primary 
care clinic, laboratory and treatment data are essential so that 
the screening programme can be monitored and the impact of 
the programme can be assessed; and (vii) laboratory standards 
including a uniform quality control system are required to 
support a cervical screening programme. 
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